Singapore-based medical technology firm Biolidics Limited plans to raise S$3.13 million ($2.2 million) from a share placement exercise to fuel its business expansion and pursue new opportunities, according to a company statement.
Continue reading this premium story with a subscription to DealStreetAsia.Subscribe
Already a Subscriber? Log in
Contact us for corporate subscriptions at email@example.com